Surprisingly, SOD activity in the blood serum of ALS patients was 25% higher (118.1 ± 9.2 U/ml) compared to the control group (88.8 ± 13.1 U/ml) (Fig. 1C). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.